BioSpace News Archive

Ms. Myers has more than fourteen years of experience designing, launching, marketing, and selling healthcare solutions.

NeuroVive Pharmaceutical AB today announced positive U.S. Food and Drug Administration (FDA) feedback on its NeuroSTAT clinical development plan for the treatment of moderate to severe Traumatic Brain Injury (TBI) at a pre-IND (Investigational New Drug) meeting.

European Immuno-Oncology Consortium to present update on TMB standardization efforts and clinical research data derived from new Oncomine Tumor Mutation Load Assay workflow

Hereditary Neuropathy Foundation (HNF) today announced it is conducting a ground-breaking Externally-led Patient-Focused Drug Development Meeting (PFDD) for Charcot-Marie-Tooth Disease (CMT) and Inherited Neuropathies (IN) on Friday, September 28, 2018 at the College Park Marriott Hotel and Conference Center in Hyattsville, MD.

The Canadian Medical Association (CMA), in partnership with the CMA Foundation, is thrilled to announce the 14 recipients of the inaugural Healthy Canadians Grants, a program designed to support grassroots health-related initiatives across the country.

Remarks will focus primarily on data from the Phase 2b study of LY3298176, a GIP and GLP-1 dual receptor agonist.

Co-funded Research to be Led by Dr. Mark Pimentel’s Lab to Further Evaluate the Efficacy and Safety of SYN-010 in a 12-Week, Placebo-Controlled, Phase 2 Clinical Study

Three issued U.S. patents add to existing protection for clinical drug candidates derived from Protagonist’s innovative peptide technology platform

The Hyundai Hope On Wheels Foundation embarks on a nationwide tour this September in honor of National Childhood Cancer Awareness Month to award $14.1 million to 38 researchers, surpassing $145 million in total giving.

Grant supports translational research for hepcidin mimetic PTG-300 for potential treatment of rare blood disorders